| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), XNCR's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 546.3K | $6.02M | - | |
| VP | 263.8K | $2.91M | - | |
| VP | 76.9K | $847.6K | - | |
| CFO | 75.9K | $932.5K | - | |
| Dir | 30.0K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 2, 2025 | Valente Nancy61 | EVP, Chief Development Officer | Sell | 4,616 | $11.03 | $50,914.48 | -8.6% | -26.1% | +12.7% | |
| Apr 10, 2025 | Cornelissen Bart Jan | Sr. Vice President &CFO | Sell | 3,750 | $8.06 | $30,232.87 | -5.8% | +17.8% | +56.8% | |
| Mar 10, 2025 | Valente Nancy61 | EVP, Chief Development Officer | Sell | 2,565 | $13.60 | $34,876.56 | -4.6% | -29.9% | -12.0% | |
| Mar 10, 2025 | Eckert Celia73 | SVP, General Counsel | Sell | 5,740 | $13.60 | $78,047.35 | -8.3% | -29.9% | -12.0% | |
| Mar 10, 2025 | Desjarlais John R74 | Sr. Vice President &CSO | Sell | 9,697 | $13.60 | $131,851.08 | -3.9% | -29.9% | -12.0% | |
| Mar 10, 2025 | Dahiyat Bassil I73 | President &CEO | Sell | 19,716 | $13.60 | $268,080.42 | -4.1% | -29.9% | -12.0% | |
| Dec 4, 2024 | Montgomery Alan Bruce61 | Director | Sale+OE10b5-1 | 14,722 | $27.03 | $397,930.92 | -61.7% | -46.0% | -30.8% | |
| Nov 21, 2024 | Dahiyat Bassil I73 | President &CEO | Sale+OE10b5-1 | 49,278 | $24.07 | $1,186,362.92 | -12.3% | -32.8% | -34.1% | |
| Nov 13, 2024 | Dahiyat Bassil I73 | President &CEO | Sale+OE10b5-1 | 3,366 | $24.02 | $80,841.90 | -0.9% | -31.7% | -40.7% | |
| Nov 11, 2024 | Desjarlais John R74 | Sr. Vice President &CSO | Sale+OE10b5-1 | 68,684 | $23.48 | $1,612,638.50 | -25.6% | -27.8% | -36.2% |